ABOUT

The Texas Healthcare & Bioscience Institute (THBI) works to promote effective legislation and a steady regulatory environment at the state and federal levels. With a focus on using advocacy as a tool to create a more favorable business environment for various healthcare entities, we work with government and industry leaders to attract new participants in the life sciences.


The mission of the Texas Healthcare and Bioscience Institute is to develop and advocate policies and actions that promote biomedical science, biotechnology, agriculture and medical device innovation in Texas.

 

Our members not only have a voice at the Capitol through our revered legislative team, but they also benefit from extensive networking in the healthcare space across Texas. THBI is the leading health policy voice in the state, influencing legislation that has led to economic investment and medical breakthroughs for over 20 years.

THBI LEADERSHIP

David R. Margrave
Chairman | Lantern Pharma Inc.

Shreekanth Mandayam
Vice Chairman | Texas State University


Holli Hill

Secretary | Novartis Pharmaceuticals


Bradley Westmoreland

Treasurer | Genentech, Inc.


Victoria Ford 
President & CEO | THBI



Brynna Clark
PhRMA

Molly Czepiel
Merck

Kyle Kamrath

Vertex Pharmaceuticals


Gilbert Loredo 
UT Health San Antonio

Melisa McEwen

AstraZeneca


Mark Moreno
MD Anderson Cancer Center


Zoey Powers

Eli Lilly & Company



Jack Quinn

Regeneron

Ramamoorthy Ramesh
Rice University


Maurice Rigsby
Johnson & Johnson


Jeffrey L. Wade

Consultant


Jeffrey Woodhouse

GSK


(open)

Pfizer

THBI STAFF

Victoria Ford, MPA

President & CEO

Miranda Goodsheller

Director of Operations & Economic Development

Alex Harber

Executive Assistant

Danielle Lobsinger Bush

Director of Policy

Julia Perkins

Director of Membership & Programming